Association Between Eosinophils and Readmission in Patients with Eosinophil-Fluctuating AECOPD: A Multi-Threshold PWP-GT Analysis
- 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People’s Republic of China
- 2Department of Respiratory and Critical Care Medicine, Anhui No.2 Provincial People’s Hospital, Hefei, 230041, People’s Republic of China
Abstract
Purpose: Although peripheral blood eosinophils (EOS) have been extensively studied as a biomarker for chronic obstructive pulmonary disease (COPD), the association between EOS and COPD prognosis remains controversial. Our objective was to analyze the relationship between EOS and readmission in patients with EOS-fluctuating COPD.
Patients and Methods: This is a retrospective, single-center study of inpatients admitted to the Department of Respiratory and Critical Care Medicine at Anhui Second People’s Hospital between January 2021 and June 2026 due to at least two acute exacerbations of COPD (AECOPD). Prentice–Williams–Peterson Gap Time (PWP-GT) models were established using EOS thresholds of 100cells/ μL, 200cells/ μL, 30cells/ μL, 1%, 2%, and 3%. The relationship between EOS levels at the time of the previous hospitalization and the time interval until the next hospitalization was analyzed.
Results: The study included 224 patients and 1095 hospitalizations. EOS ≥ 300 cells/ μL (HR = 0.767, 95% CI: 0.602–0.977, P = 0.032) and EOS% ≥ 3% (HR = 0.804, 95% CI: 0.671–0.965, P = 0.019) were independent protective factors against readmission. EOS ≥ 100 cells/μL (P = 0.070), EOS ≥ 1% (P = 0.100), EOS ≥ 2% (P = 0.094), and EOS ≥ 200 cells/μL (P = 0.189) were not significantly associated with readmission. The protective effects of EOS ≥ 300 cells/μL and EOS% ≥ 3% were consistent across subgroup analyses stratified by sex, history of acute exacerbations, mechanical ventilation, and comorbidities. The protective effect of EOS was more pronounced in patients aged <65 years and in those using inhaled pharmacotherapy.
Conclusion: Patients with EOS-fluctuating AECOPD have a unique prognostic profile. Higher eosinophil levels were associated with a lower risk of rehospitalization.
Related
- Association between metabolic overweight/obesity phenotypes and readmission risk in patients with Immune Thrombocytopenia (ITP): a national retrospective study.
- Association between maintenance doses of mood stabilizers and antipsychotics and risk of readmission in first-episode bipolar disorder
- Association of unmet discharge needs on readmission or mortality among acute respiratory failure survivors during the COVID-19 pandemic: The Addressing Post-Intensive Care Syndrome (APICS-COVID) multicenter prospective cohort study
- Association of the red cell distribution width/albumin ratio with 6-month readmission risk in heart failure patients
- Cadherin-related family member 3 upregulates the effector functions of eosinophils
BibTeX
@article{gong2026association,
title = {{Association Between Eosinophils and Readmission in Patients with Eosinophil-Fluctuating AECOPD: A Multi-Threshold PWP-GT Analysis}},
author = {Yaya Gong and Peng Zhang and Hongyan Sun and Ran Wang},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2026},
month = nov,
doi = {10.2147/copd.s651841},
url = {https://doi.org/10.2147/copd.s651841},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Association Between Eosinophils and Readmission in Patients with Eosinophil-Fluctuating AECOPD: A Multi-Threshold PWP-GT Analysis
AU - Yaya Gong
AU - Peng Zhang
AU - Hongyan Sun
AU - Ran Wang
PY - 2026
DA - 2026/11/01
JO - International Journal of Chronic Obstructive Pulmonary Disease
DO - 10.2147/copd.s651841
UR - https://doi.org/10.2147/copd.s651841
AB - Purpose: Although peripheral blood eosinophils (EOS) have been extensively studied as a biomarker for chronic obstructive pulmonary disease (COPD), the association between EOS and COPD prognosis remains controversial. Our objective was to analyze the relationship between EOS and readmission in patients with EOS-fluctuating COPD. Patients and Methods: This is a retrospective, single-center study of inpatients admitted to the Department of Respiratory and Critical Care Medicine at Anhui Second People’s Hospital between January 2021 and June 2026 due to at least two acute exacerbations of COPD (AECOPD). Prentice–Williams–Peterson Gap Time (PWP-GT) models were established using EOS thresholds of 100cells/ μL, 200cells/ μL, 30cells/ μL, 1%, 2%, and 3%. The relationship between EOS levels at the time of the previous hospitalization and the time interval until the next hospitalization was analyzed. Results: The study included 224 patients and 1095 hospitalizations. EOS ≥ 300 cells/ μL (HR = 0.767, 95% CI: 0.602–0.977, P = 0.032) and EOS% ≥ 3% (HR = 0.804, 95% CI: 0.671–0.965, P = 0.019) were independent protective factors against readmission. EOS ≥ 100 cells/μL (P = 0.070), EOS ≥ 1% (P = 0.100), EOS ≥ 2% (P = 0.094), and EOS ≥ 200 cells/μL (P = 0.189) were not significantly associated with readmission. The protective effects of EOS ≥ 300 cells/μL and EOS% ≥ 3% were consistent across subgroup analyses stratified by sex, history of acute exacerbations, mechanical ventilation, and comorbidities. The protective effect of EOS was more pronounced in patients aged <65 years and in those using inhaled pharmacotherapy. Conclusion: Patients with EOS-fluctuating AECOPD have a unique prognostic profile. Higher eosinophil levels were associated with a lower risk of rehospitalization.
SN - 1176-9106
SN - 1178-2005
ER -